Folia Biologica
Journal of Cellular and Molecular Biology, Charles University 

Crossref logo

Fol. Biol. 2010, 56, 183-193

https://doi.org/10.14712/fb2010056040183

Gene Regulation by BCL3 in a Cervical Cancer Cell Line

V. Maldonado1, M. Espinosa2, F. Pruefer2, N. Patiño2, G. Ceballos-Cancino2, U. Urzua3, N. Juretic3, Jorge Melendez-Zajgla2

1Molecular Biology Laboratory, Instituto Nacional de Cancerologia, Mexico City, Mexico
2Cancer Functional Genomics Laboratory, National Institute of Genomic Medicine, Mexico City, Mexico
3PBCM, ICBM Facultad de Medicina, Universidad de Chile, Santiago, Chile

Received November 2009
Accepted March 2010

References

1. Aggarwal, B. B. (2004) Nuclear factor-κB: the enemy within. Cancer Cell 6, 203-208. <https://doi.org/10.1016/j.ccr.2004.09.003>
2. Bandala, E., Espinosa, M., Maldonado, V., Melendez-Zajgla, J. (2001) Inhibitor of apoptosis-1 (IAP-1) expression and apoptosis in non-small-cell lung cancer cells exposed to gemcitabine. Biochem. Pharmacol. 62, 13-19. <https://doi.org/10.1016/S0006-2952(01)00632-3>
3. Bauer, A., Villunger, A., Labi, V., Fischer,S. F., Strasser, A., Wagner, H., Schmid, R. M., Hacker, G. (2006) The NF-κB regulator Bcl3 and the BH3-only proteins Bim and Puma control the death of activated T cells. Proc. Natl. Acad. Sci. USA 103, 10979-10984. <https://doi.org/10.1073/pnas.0603625103>
4. Blobel, C. P. (2005) ADAMs: key components in EGFR signalling and development. Nat. Rev. Mol. Cell Biol. 6, 32-43. <https://doi.org/10.1038/nrm1548>
5. Brocke-Heidrich, K., Ge, B., Cvijic, H., Pfeifer, G., Loffler, D., Henze, C., McKeithan, T. W., Horn, F. (2006) BCL3 is induced by IL-6 via Stat3 binding to intronic enhancer HS4 and represses its own transcription. Oncogene 25, 7297-7304. <https://doi.org/10.1038/sj.onc.1209711>
6. Cogswell, P. C., Guttridge, D.C., Funkhouser, W.K., Baldwin, A.S., Jr. (2000) Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κ B2/p52 and for Bcl3. Oncogene 19, 1123-1131. <https://doi.org/10.1038/sj.onc.1203412>
7. Cristofanon, S., Morceau, F., Scovassi, AI., Dicato, M., Ghibelli, L., Diederich, M. (2009) Oxidative, multistep activation of the noncanonical NF-κB pathway via disulfide Bcl3/p50 complex. FASEB J. 23, 45-57. <https://doi.org/10.1096/fj.07-104109>
8. Dave, S. S., Fu, K., Wright, G. W., Lam, L. T., Kluin, P., Boerma, E. J., Greiner, T. C., Weisenburger, D. D., Rosenwald, A., Ott, G., Muller-Hermelink, H. K., Gascoyne, R. D., Delabie, J., Rimsza, L. M., Braziel, R. M., Grogan, T. M., Campo, E., Jaffe, E. S., Dave, B. J., Sanger, W., Bast, M., Vose, J. M., Armitage, J. O., Connors, J. M., Smeland, E. B., Kvaloy, S., Holte, H., Fisher, R. I., Miller, T. P., Montserrat, E., Wilson, W. H., Bahl, M., Zhao, H., Yang, L., Powell, J., Simon, R., Chan, W. C., Staudt, L. M. (2006) Molecular diagnosis of Burkitt’s lymphoma. N. Engl. J. Med. 354, 2431-2442. <https://doi.org/10.1056/NEJMoa055759>
9. Fujita, T., Nolan, G. P., Liou, H. C., Scott, M. L., Baltimore, D (1993) The candidate proto-oncogene Bcl3 encodes a transcriptional coactivator that activates through NF-κB p50 homodimers. Genes Dev. 7, 1354-1363. <https://doi.org/10.1101/gad.7.7b.1354>
10. Gilmore, T. D (2006) Introduction to NF-κB: players, pathways, perspectives. Oncogene 25, 6680-6684. <https://doi.org/10.1038/sj.onc.1209954>
11. Gough, D. J., Corlett, A., Schlessinger, K., Wegrzyn, J., Larner, A. C., Levy, D. E. (2009) Mitochondrial STAT3 supports Ras-dependent oncogenic transformation. Science 324, 1713-1716. <https://doi.org/10.1126/science.1171721>
12. Hummel, M., Bentink, S., Berger, H., Klapper, W., Wessendorf, S., Barth, T. F., Bernd, H. W., Cogliatti, S. B., Dierlamm, J., Feller, A. C., Hansmann, M. L., Haralambieva, E., Harder, L., Hasenclever, D., Kuhn, M., Lenze, D., Lichter, P., Martin-Subero, J. I., Moller, P., Muller-Hermelink, H. K., Ott, G., Parwaresch, R. M, Pott, C., Rosenwald, A., Rosolowski, M., Schwaenen, C., Sturzenhofecker, B., Szczepanowski, M., Trautmann, H., Wacker, H. H., Spang, R., Loeffler, M., Trumper, L., Stein, H., Siebert, R. (2006) A biologic definition of Burkitt’s lymphoma from transcriptional and genomic profiling. N. Engl. J. Med. 354, 2419-2430. <https://doi.org/10.1056/NEJMoa055351>
13. Ji, H., Zhao, X., Yuza, Y., Shimamura, T., Li, D., Protopopov, A., Jung, B. L., McNamara, K., Xia, H., Glatt, K. A., Thomas, R. K., Sasaki, H., Horner, J. W., Eck, M., Mitchell, A., Sun, Y., Al-Hashem, R., Bronson, R. T., Rabindran, S. K., Discafani, C. M., Maher, E., Shapiro, G.I., Meyerson, M., Wong, K. K. (2006) Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitors. Proc. Natl. Acad. Sci. USA 103, 7817-7822. <https://doi.org/10.1073/pnas.0510284103>
14. Kashatus, D., Cogswell, P., Baldwin, A. S. (2006) Expression of the Bcl3 proto-oncogene suppresses p53 activation. Genes Dev. 20, 225-235. <https://doi.org/10.1101/gad.1352206>
15. Konnikova, L., Simeone, M. C., Kruger, M. M., Kotecki, M., Cochran, B. H. (2005) Signal transducer and activator of transcription 3 (STAT3) regulates human telomerase reverse transcriptase (hTERT) expression in human cancer and primary cells. Cancer Res. 65, 6516-6520. <https://doi.org/10.1158/0008-5472.CAN-05-0924>
16. Massoumi, R., Chmielarska, K., Hennecke, K., Pfeifer, A., Fassler, R. (2006) Cyld inhibits tumor cell proliferation by blocking Bcl3-dependent NF-κB signaling. Cell 125, 665-677. <https://doi.org/10.1016/j.cell.2006.03.041>
17. Mendoza, J., Zamora, R., Gallardo, J. C., Ceballos, G., Aldana, A., Espinosa, M., Maldonado, V., Melendez-Zajgla, J. (2006) NF-κB does not influence the induction of apoptosis by ukrain. Cancer Biol. Ther. 5, 788-793. <https://doi.org/10.4161/cbt.5.7.2752>
18. Park, S. G., Chung, C., Kang, H., Kim, J. Y., Jung, G. (2006) Up-regulation of cyclin D1 by HBx is mediated by NF-κ B2/BCL3 complex through κB site of cyclin D1 promoter. J. Biol. Chem. 281, 31770-31777. <https://doi.org/10.1016/S0021-9258(19)84092-9>
19. Perkins, N. D. (2007) Integrating cell-signalling pathways with NF-κB and IKK function. Nat. Rev. Mol. Cell Biol. 8, 49-62. <https://doi.org/10.1038/nrm2083>
20. Rhodes, D. R., Yu, J., Shanker, K., Deshpande, N., Varambally, R., Ghosh, D., Barrette, T., Pandey, A., Chinnaiyan, A. M. (2004) ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6, 1-6. <https://doi.org/10.1016/S1476-5586(04)80047-2>
21. Rocha, S., Martin, A. M., Meek, D. W., Perkins, N. D. (2003) p53 represses cyclin D1 transcription through down regulation of Bcl3 and inducing increased association of the p52 NF-κB subunit with histone deacetylase 1. Mol. Cell Biol. 23, 4713-4727. <https://doi.org/10.1128/MCB.23.13.4713-4727.2003>
22. Spandidos, A., Wang, X., Wang, H., Dragnev, S., Thurber, T., Seed, B. (2008) A comprehensive collection of experimentally validated primers for Polymerase Chain Reaction quantitation of murine transcript abundance. BMC Genomics 9, 633. <https://doi.org/10.1186/1471-2164-9-633>
23. Thornburg, N. J., Pathmanathan, R., Raab-Traub, N. (2003) Activation of nuclear factor-κB p50 homodimer/Bcl3 complexes in nasopharyngeal carcinoma. Cancer Res. 63, 8293-8301.
24. Westerheide, S. D., Mayo, M. W., Anest, V., Hanson, J. L., Baldwin, A. S., Jr. (2001) The putative oncoprotein Bcl3 induces cyclin D1 to stimulate G(1) transition. Mol. Cell Biol. 21, 8428-8436. <https://doi.org/10.1128/MCB.21.24.8428-8436.2001>
25. Zhao, Y., Ramakrishnan, A., Kim, K. E., Rabson, A. B. (2005) Regulation of Bcl3 through interaction with the Lck tyrosine kinase. Biochem. Biophys. Res. Commun. 335, 865-873. <https://doi.org/10.1016/j.bbrc.2005.07.162>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive